Featured News

The Celiac Disease Foundation congratulates David Baker, Demis Hassabis, and John Jumper on winning the 2024 Nobel Prize in Chemistry. Baker and his colleagues have transformed protein design, structure, and prediction using artificial intelligence, paving the way for the development of new therapeutics targeting specific proteins. For the celiac community, these advancements are particularly significant.…

A new study from researchers at Cincinnati Children’s Hospital may have found a method to predict celiac disease in patients with type 1 diabetes (T1DM). Celiac disease prevalence in children with T1DM is approximately 5-8%, which is significantly higher than the general population. Because these conditions frequently co-occur, screening for celiac disease is recommended in…

What if there was a way to help your immune system become more tolerant of gluten? That’s the potential of VTP-1000, an investigational immunotherapy being studied in the AVALON celiac disease clinical trial.

Researchers from the University of California Davis may have found a way to make wheat safer for those with celiac disease and improve the overall quality of gluten-free bread.  Wheat contains proteins called gliadins and glutenins that are important for making dough strong and elastic, but they also contain certain parts (called epitopes) that can…

Doctoral student Adriana Carrieri from the behavioral nutrition program at Teacher’s College Columbia University is the latest recipient of the Celiac Disease Foundation’s Rising Villus Student Research Award for her research on how young adults with celiac disease navigate the transition from high school to college. This period is often filled with new freedoms and…

A team of interdisciplinary researchers at McMaster University in Canada, along with teams from the US, Australia, and Argentina, have made a breakthrough in understanding how the reaction to gluten starts in individuals with celiac disease. It was previously believed that immune cells inside the gut exclusively triggered the inflammatory response to gluten. However, this…

The Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, announces Leslie Saba, MB BCh BAO, as the recipient of the Celiac Disease Foundation-Jocelyn Silvester Rising Villus Student Research Award, an award designed to foster interest in the field of celiac disease research among promising medical students, graduate students, and residents.  Dr.…

New research from Tampere University in Finland shows exciting progress in a new drug for celiac disease. This drug, ZED1227 could be used alongside a gluten-free diet to help manage celiac disease.  In celiac disease, gluten causes inflammation and damage to the intestines. This happens because gluten attaches to specific proteins in the body called…

The Celiac Disease Foundation is committed to accelerating research aimed at finding potential treatments and cures for celiac disease beyond the gluten-free diet. In order to do this, we need patients like you to participate in clinical trials. Clinical trials are necessary to determine if new treatments are safe and effective. Your involvement not only advances scientific…

A new international study published in the journal Gastroenterology sheds light on the extensive economic burden of celiac disease. In addition to the cost of gluten-free  foods, the authors address several economic issues associated with celiac disease, including direct costs like healthcare services and medical management, as well as indirect costs such as reduced work…